Literature DB >> 16818777

Endogenous tissue-type plasminogen activator is protective during Escherichia coli-induced abdominal sepsis in mice.

Rosemarijn Renckens1, Joris J T H Roelofs, Sandrine Florquin, Alex F de Vos, Jennie M Pater, H Roger Lijnen, Peter Carmeliet, Cornelis van 't Veer, Tom van der Poll.   

Abstract

Sepsis is associated with enhanced production of tissue-type plasminogen activator (tPA). We investigated the function of endogenous tPA in the immune responses to Escherichia coli-induced abdominal sepsis using tPA gene-deficient (tPA(-/-)) and normal wild-type (WT) mice. tPA(-/-) mice demonstrated an impaired defense against E. coli peritonitis as indicated by higher bacterial loads at the primary site of the infection, enhanced dissemination, and reduced survival. The protective function of tPA was independent of plasmin since plasminogen gene-deficient (Plg(-/-)) mice were indistinguishable from WT mice. Relative to WT mice, tPA(-/-) mice demonstrated similar neutrophil counts in the peritoneal cavity despite much higher bacterial loads and higher local concentrations of neutrophil attracting chemokines, suggesting a reduced migratory response. In line, tPA(-/-) mice demonstrated a reduced thioglycolate-induced neutrophil influx into the peritoneal cavity and i.p. injection of WT mice with a replication-defective adenoviral vector expressing tPA caused an enhanced cell migration to the peritoneal cavity during E. coli peritonitis. These findings identify a novel protective function of tPA in abdominal sepsis caused by E. coli that seems independent of its role in the generation of plasmin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16818777     DOI: 10.4049/jimmunol.177.2.1189

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Differential activation of RAGE by HMGB1 modulates neutrophil-associated NADPH oxidase activity and bacterial killing.

Authors:  Jean-Marc Tadié; Hong-Beom Bae; Sami Banerjee; Jaroslaw W Zmijewski; Edward Abraham
Journal:  Am J Physiol Cell Physiol       Date:  2011-10-19       Impact factor: 4.249

2.  Ligands of the receptor for advanced glycation end products, including high-mobility group box 1, limit bacterial dissemination during Escherichia coli peritonitis.

Authors:  Marieke A D van Zoelen; Ahmed Achouiti; Ann-Marie Schmidt; Huan Yang; Sandrine Florquin; Kevin J Tracey; Tom van der Poll
Journal:  Crit Care Med       Date:  2010-06       Impact factor: 7.598

3.  TLR4 inhibition impairs bacterial clearance in a therapeutic setting in murine abdominal sepsis.

Authors:  Miriam H P van Lieshout; Tom van der Poll; Cornelis van't Veer
Journal:  Inflamm Res       Date:  2014-08-15       Impact factor: 4.575

4.  Chitinase-like proteins are candidate biomarkers for sepsis-induced acute kidney injury.

Authors:  B Maddens; B Ghesquière; R Vanholder; D Demon; J Vanmassenhove; K Gevaert; E Meyer
Journal:  Mol Cell Proteomics       Date:  2012-01-10       Impact factor: 5.911

5.  Delineation of the role of Toll-like receptor signaling during peritonitis by a gradually growing pathogenic Escherichia coli.

Authors:  Cornelis van 't Veer; Petra S van den Pangaart; Daniëlle Kruijswijk; Sandrine Florquin; Alex F de Vos; Tom van der Poll
Journal:  J Biol Chem       Date:  2011-06-20       Impact factor: 5.157

6.  Activation of AMPK enhances neutrophil chemotaxis and bacterial killing.

Authors:  Dae Won Park; Shaoning Jiang; Jean-Marc Tadie; William S Stigler; Yong Gao; Jessy Deshane; Edward Abraham; Jaroslaw W Zmijewski
Journal:  Mol Med       Date:  2013-11-08       Impact factor: 6.354

7.  CD44 deficiency is associated with enhanced Escherichia coli-induced proinflammatory cytokine and chemokine release by peritoneal macrophages.

Authors:  Gerritje J W van der Windt; Cornelis van 't Veer; Sandrine Florquin; Tom van der Poll
Journal:  Infect Immun       Date:  2009-11-09       Impact factor: 3.441

8.  Accelerated dosing frequency of a pulmonary formulation of tissue plasminogen activator is well-tolerated in mice.

Authors:  Kathleen A Stringer; Meghan Tobias; John S Dunn; Jackie Campos; Zachary Van Rheen; Mitra Mosharraf; Rajiv Nayar
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-07-29       Impact factor: 2.557

9.  Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice.

Authors:  Yanqing Gong; Erika Hart; Aleksey Shchurin; Jane Hoover-Plow
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

10.  Safety of prolonged, repeated administration of a pulmonary formulation of tissue plasminogen activator in mice.

Authors:  Nicholas P Lackowski; Josh E Pitzer; Meghan Tobias; Zachary Van Rheen; Rajiv Nayar; Mitra Mosharaff; Kathleen A Stringer
Journal:  Pulm Pharmacol Ther       Date:  2009-10-29       Impact factor: 3.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.